1126-62-1 Usage
General Description
(3,4-dihydroxyphenyl)acetonitrile is a chemical compound with the formula C8H7NO2. It is a phenolic compound that contains two hydroxyl groups and a nitrile group. (3,4-DIHYDROXYPHENYL)ACETONITRILE is often used in organic synthesis as a building block for various pharmaceuticals and agrochemicals. It is also a key intermediate in the synthesis of amino acids and other organic compounds. (3,4-dihydroxyphenyl)acetonitrile can also be used as a precursor in the production of dyes, pigments, and other specialty chemicals. Due to its versatile nature, this compound has a wide range of applications in the chemical and pharmaceutical industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1126-62-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,1,2 and 6 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1126-62:
(6*1)+(5*1)+(4*2)+(3*6)+(2*6)+(1*2)=51
51 % 10 = 1
So 1126-62-1 is a valid CAS Registry Number.
InChI:InChI=1/C8H7NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3H2
1126-62-1Relevant articles and documents
METHOD FOR PREPARATION OF HYDROXYTYROSOL
-
Page/Page column 10, (2017/09/15)
The invention discloses a method for the preparation of (3,4-dihydroxyphenyl)acetic acid or its ester starting from the respective nitrile, and the conversion of (3,4-dihydroxyphenyl)acetic acid ester to hydroxytyrosol.
MODULATORS OF LIPID STORAGE
-
Paragraph 00112; 00113; 0204, (2013/06/06)
Disclosed are compounds of formulas I, II, and III: Formulas I, II, and III wherein R1-R19 and n are as described herein, or pharmaceutically acceptable salts thereof, or an enantiomer thereof or a conjugate thereof wherein the conju
Modulators of ATP-binding cassette transporters
-
Page/Page column 80, (2008/06/13)
Compounds of the present invention and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.
